| Name | AYUMI Pharmaceutical Corporation | 
|---|---|
| Date established | January 2015 | 
| Capital | 100 million Japanese yen | 
| Employees | 319(As of April 1, 2023) | 
| Main business | Manufacture and sale of medical drugs, including rheumatism drugs and analgesic antipyretics | 
| Representative director | President Jugo Tsumura | 
| Principal shareholders | private equity funds managed by Blackstone (NYSE: BX) | 
| Head office | Kabukiza Tower 19F 4-12-15 Ginza Chuo-ku, Tokyo 104-0061 JAPAN Tel: +81-3-6264-3540 | 
▼ COMPANY INDEX